Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

XXXXXXX

Xxxxxxxxxxxx zdravotnictví

ze xxx 20. xxxxxxxxx 2014

o xxxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2015

Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 odst. 1 xxxx. x) zákona x. 258/2000 Sb., x ochraně veřejného xxxxxx x o xxxxx některých xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx složení xxxxxxxxxx xxxxx pro pravidelná, xxxxxxxx x mimořádná xxxxxxxx pro xxx 2015:

1. Xxxxxxxxx složení xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx

1x) kombinovaná xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX):

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxx haemagglutinum xxxxxxxxxxxx

Xxxxxxxxx xxxxxxxxx externae proteinum

Diphtheriae xxxxxxxxxx

Xxxxxx xxxxxxxxxx xxx.

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1

Virus xxxxxxxxxxxxxxx xxxxxxxxxxx typus 2

Virus xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3

Xxxxxxxxxx Hib: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), xxxxxx hepatitidě B, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x ( DTaPHibVHBIPV)

Diphtheriae anatoxinum

Tetani xxxxxxxxxx

Xxxxxxxx Bordetelly pertussis

Pertussis xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum

Virus Poliomyelitidis (xxxxxxxxxxxx)

xxxxx 1 (Xxxxxxx)

xxxxx 2 (XXX-1)

xxxxx 3 (Xxxxxxx)

Xxxxxxxxx xxxxxxxxx hepatitidy X

Xxxxxxxxxxx influenzae typu x xxxxxxxxxxxxxxx

(Xxxxxxxxxxxxxxxxxxx phasphas)

conjugata xxx tetani anatoxinum

1b) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), tetanu (XXxX):

Xxxxxxxxxxx anatoxinum ≥ 30 xxxxxxxxxxxxx jednotek

Tetani xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Hemofilem xxxxxxxxxx x (DTaPHib):

Diphtheriae xxxxxxxxxx ........................................... min. 30 xxxxxxxxxxxxx jednotek

Tetani xxxxxxxxxx .................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) .... 25 mikrogramů

Pertactinum (69xX) ................................................... 8 mikrogramů

Haemophilus xxxxxxxxxx X ....................................... 10 xxxxxxxxxx

xxx xxxxxxxxx xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) xxx Anatoxino xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx tetanu:

Tetani xxxxxxxxxx ................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx proti virové xxxxxxxxxx X xx 15 xxx věku:

Antigenum xxxxxxxxx xxxxxxxxxxx X .......................... 10 xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx 16 let x xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X ........................... 20 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx xxxxx xxxxxxxxxx (Schwarz) xxx. 10^3,0 xxxxxxxx xxxxx pro buněčnou xxxxxxx₅₀

Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) xxx. 10^3,7 xxxxxxxx dávka xxx xxxxxxxx kulturu₅₀

Rubeolae xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 10^3,0 infekční xxxxx xxx buněčnou xxxxxxx₅₀

1xx) xxxxxxxx xxxxx proti xxxxxx xxxxxxxx obrně x xxxxxxxxxxxx formě:

Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ........... 40 antigenních X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 2 (XXX-1) ................ 8 antigenních X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx X jednotek*

* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx imunochemické xxxxxx.

1x) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10A, 11 X, 12X, 14, 15X, 17X, 18X, 19X, 19F, 20, 22X, 23F, 33F ...... 25 xxxxxxxxxx x xxxxxxx sérotypu

1j) xxxxxxxx látka konjugovaná xxxxx xxxxxxxxxxxxx infekcím:

Pneumococcale xxxxxxxxxxxxxxx sérotypus 1

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 3

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 5

Pneumococcale xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19F

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 23X

1xx) xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma):

Diphtheriae xxxxxxxxxx ............................... xx méně xxx 2 xxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx ........................................ xx xxxx xxx 20 mezinárodních xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx anatoxinum................................... 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx filamentosum ... 8 mikrogramů

Pertaktin ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx) .............................. 40 X jednotek xxxxxxxx

xxxxx 2 (xxxx XXX-1) ................................... 8 X jednotek xxxxxxxx

xxxxx 3 (kmen Saukett) ................................ 32 X xxxxxxxx antigenu

NEBO

1kb) očkovací xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx ....................................... xxxx xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Xx)

Xxxxxxxxx xxxxxx ....................................... více xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx toxoid ................................ 2,5 xxxxxxxxxx

Xxxxxxxxxxxx xxxxxxxxxxxx ................. 5 mikrogramů

Fimbrie xxxx 2+3 ................................ 5 xxxxxxxxxx

Xxxxxxxxx ............................................. 3 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) ... 40 antigenních X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) ... 8 xxxxxxxxxxx X xxxxxxxx

Xxxxx poliomyelitis xxxx 3 (xxxxxxxxxxxx) ... 32 xxxxxxxxxxx X xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx tuberkulóze:

Mycobacterium xxxxx xxxxxxxxxx (XXX) xxxxxxx Xxxxxxx 1331 ... 0,75 xx&xxxx;≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xxx osoby xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid A (XXX) 50 xxxxxxxxxx x 1 dávce

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx

2x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xx formuli xxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X 20 xxxxxxxxxx

2x) očkovací xxxxx xxxxx xxxxxxxxx

Xxxxx xxxxxx xxxxxxxxxxx (xxxx Wistar xxxxxx PM/WI 38 1503-3M xxxx xxxx rovno 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 xxxxx (0,5 ml)

2c) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx A ve xxxxxxx pro xxxxxxx:

Xxxxxxxxx X xxxxx inactivatum

3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxx

3x) očkovací xxxxx xxxxx xxxxxx hepatitidě X ve xxxxxxx xxx dospělé:

Hepatitis X xxxxx xxxxxxxxxxx

3x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx pro xxxx:

Xxxxx xxxxxxxxx A xxxxxxxxxxx

X xxxx 2015 s xxxxxxx xx plánovanou xxxxxxxxxx vyhlášky č. 537/2006 Sb., x xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, xxxxx xxxxxxxx případnou úpravu xxxxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx xxxxxxxx publikováním xxxxxx xxxxxxxxxxx xxxxxxx těchto xxxxxxxxxx xxxxx xx Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Němeček, XXX, x. x.

Xxxxxxxxx

Xxxxxx xxxxxxx č. 278/2014 Xx. nabyl xxxxxxxxx xxxx 13.12.2014.

Ke xxx xxxxxxxx xxxxxx xxxxxxx nebyl xxxxx xx doplňován.

Znění xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.